(Q41110675)

26 September 2017

An optimised method for the production of MERS-CoV spike expressing viral pseudotypes (English)

1 reference

Middle East respiratory syndrome coronavirus

26 September 2017

0 references

author

Nigel J. Temperton

series ordinal

3

1 reference

26 September 2017

K Grehan

1

0 references

Francesca Ferrara

object named as

F Ferrara

series ordinal

2

0 references

publication date

13 October 2015

1 reference

26 September 2017

1 reference

26 September 2017

2

1 reference

26 September 2017

379-384

1 reference

Pseudotype-based neutralization assays for influenza: a systematic analysis.

26 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625112

Bat origins of MERS-CoV supported by bat coronavirus HKU4 usage of human receptor CD26

26 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625112

Multiplex evaluation of influenza neutralizing antibodies with potential applicability to in-field serological studies

26 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625112

Role of the spike glycoprotein of human Middle East respiratory syndrome coronavirus (MERS-CoV) in virus entry and syncytia formation

26 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625112

A safe and convenient pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for viral entry inhibitors against the novel human coronavirus MERS-CoV

26 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625112

The human Transmembrane Protease Serine 2 is necessary for the production of Group 2 influenza A virus pseudotypes

26 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625112

The use of equine influenza pseudotypes for serological screening

26 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625112

Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors

26 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625112

Longitudinally profiling neutralizing antibody response to SARS coronavirus with pseudotypes

26 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625112

Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery

26 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625112

Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo

26 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625112

10.1016/J.MEX.2015.09.003

26 September 2017

Identifiers

DOI

1 reference

26 September 2017

1 reference

PMC publication ID

4625112

26 September 2017

PubMed publication ID

26587388

1 reference

PMC publication ID

4625112